Multi-Drug Resistant TB
Tuberculosis bedaquiline Johnson & Johnson’s TB drug deal will fail to reach all those in need

A recent deal struck between Johnson & Johnson and the Global Drug Facility promises improved access to bedaquiline in a number of low income countries, but fails to address structural problems

Commitment, determination and solidarity are key to success of ‘End TB in Bangladesh’

Bangladesh’s national tuberculosis program is picking up after a blow dealt by the COVID-19 pandemic, but room for improvement remains

India’s fight against TB: Govt’s eerie silence over worsening situation, drug stock-outs

While India continues its poor performance in the global fight against TB, additional challenges are emerging in the form of Delamanid stock-outs and shortage of testing kits. Despite repeated inquiries from activists, the government keeps mum